News

La Chine approuve le premier vaccin au monde contre les lignées descendantes XBB du SRAS-CoV-2 en cas d’urgence

by

CHENGDU, Chine, 10 juin 2023 /PRNewswire/ — Le 8 juin 2023, le vaccin protéique Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) (cellule Sf9) développé par WestVac Biopharma/ West China Medical Center, Sichuan University a été approuvé pour une utilisation en cas d’urgence par les autorités compétentes en Chine. Il s’agit du premier vaccin COVID-19 au monde approuvé pour l’autorisation de mise sur … Read more

Čína schválila celosvetovo prvú vakcínu proti následným líniám variantu XBB SARS-CoV-2 na núdzové použitie

by

ČCHENG-TU, Čína, 10. júna 2023 /PRNewswire/ — Príslušné orgány v Číne schválili 8. júna 2023 v rámci oprávnenia na núdzové použitie (EUA) rekombinantnú trivalentnú vakcínu (XBB.1.5+BA.5+Delta) na báze proteínu COVID-19 (bunky Sf9) s názvom Coviccine® Trivalent XBB.1.5, vyvinutú spoločnosťou WestVac Biopharma/ West China Medical Center, S’-čchuanská univerzita. Ide o prvú vakcínu proti ochoreniu COVID-19 vo … Read more

Essity divests Russian operations

by

STOCKHOLM, June 10, 2023 /PRNewswire/ — The hygiene and health company Essity divests its operations in Russia. Essity has signed an agreement with a buyer and the transaction has now been approved by the Russian authorities. The transaction is expected to be finalized during the second quarter of 2023. Essity began work in April 2022 to … Read more

Menarini Group predstavila na kongrese Európskej hematologickej asociácie údaje o podskupine NEXPOVIO® (selinexor) zo štúdie BOSTON, ktoré poukazujú na klinický potenciál preparátu pri recidivujúcom/refraktérnom mnohopočetnom myelóme USA – slovenčina USA – English USA – English USA – español USA – Deutsch USA – Pусский USA – Français USA – Polski USA – čeština

by

Údaje ukazujú významné 71 % zníženie rizika progresie ochorenia alebo úmrtia v skupine selinexor + bortezomib + dexametazón (SVd) v porovnaní so skupinou bortezomib + dexametazón (Vd) pri pacientoch bez predchádzajúcej liečby inhibítormi proteazómu (PI)  Údaje ukazujú významné 47 % zníženie rizika úmrtia pri SVd v porovnaní s Vd pri pacientoch s mnohopočetným myelómom, ktorí … Read more

Essity divests Russian operations

by

STOCKHOLM, June 10, 2023 /PRNewswire/ — The hygiene and health company Essity divests its operations in Russia. Essity has signed an agreement with a buyer and the transaction has now been approved by the Russian authorities. The transaction is expected to be finalized during the second quarter of 2023. Essity began work in April 2022 to … Read more

FDA Advisory Committee votes unanimously to confirm clinical benefit of LEQEMBI® (lecanemab-irmb) for the treatment of early Alzheimer’s disease

by

STOCKHOLM, June 10, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted unanimously that the data from Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of LEQEMBI® (lecanemab-irmb) 100 … Read more

FDA Advisory Committee votes unanimously to confirm clinical benefit of LEQEMBI® (lecanemab-irmb) for the treatment of early Alzheimer’s disease

by

STOCKHOLM, June 10, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted unanimously that the data from Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of LEQEMBI® (lecanemab-irmb) 100 … Read more

Health Innovator Muscle Lab Unveils Custom Recovery Plans

by

L.A.’s Muscle Lab Creates Industry-Changing Technology with GPT-4: Pioneering Apple’s Custom Plans in the Health & Wellness Sector LOS ANGELES, June 9, 2023 /PRNewswire/ — Muscle Lab, an innovative wellness center based in California, is set to launch the first AI-driven health industry product on June 12 that will offer unprecedented personalization in recovery and wellness … Read more

Menstrual Cups Market size to grow at a CAGR of 5.18% from 2022 to 2027; Increasing Number of Product Launches Drives Growth -Technavio

by

NEW YORK, June 9, 2023 /PRNewswire/ — The menstrual cups market is estimated to grow by USD 425.44 million from 2022 to 2027. However, the growth momentum will progress at a CAGR of 5.18% during the forecast period. The market is segmented by product (reusable menstrual cups and disposable menstrual cups), distribution channel (retail and online), and geography (North America, … Read more

Growing Number of Research and Development Activities Fuels the Sector

by

DUBLIN, June 9, 2023 /PRNewswire/ — The “Automated Nucleic Acid Extraction Devices Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global automated nucleic acid extraction devices market is expected to grow from $4.84 … Read more